Please login to the form below

Not currently logged in
Email:
Password:

Quintiles joins forces with Archimedes to quantify healthcare decisions

Biopharmaceutical services company will use Archimedes' healthcare modeling technology

Quintiles has formed a partnership with a San Francisco-based healthcare modeling company to offer a new range of services aimed at reducing the time and expense of bring new therapies to market.

The biopharmaceutical services company will use Archimedes's technology to capture “predictive simulations from real-world research”, said global head of integrated clinical services Rick Sax.

“Turning data into insights will allow customers to make faster, better decisions across the product lifecycle and increase their probability of success,” he added.

Quintiles will promote and provide access to Archimedes' ARCHeS Innovator technology, which enables users to run clinically realistic virtual trials.

Mika Newton, vice president, ARCHeS and consulting business leader for Archimedes, said: “Biopharma companies are under enormous pressure to maximise the efficiency and strategic positioning of products they are developing and marketing.

“This partnership between Archimedes and Quintiles makes advanced simulation modeling and premier medical evidence accessible and fully integrated into customers' clinical research and commercial activities.”

Archimedes is a spin-off of the US managed care consortium Kaiser Permanente and has worked with the FDA, Novo Nordisk and Bristol-Myers Squibb.

2nd April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics